Cambiar Investors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,369
Closed -$554K 152
2023
Q1
$554K Sell
11,369
-2,688
-19% -$137K 0.02% 138
2022
Q4
$743K Buy
+14,057
New +$693K 0.03% 137
2020
Q1
Sell
-124,681
Closed -$4.47M 178
2019
Q4
$4.47M Sell
124,681
-12,906
-9% -$480K 0.14% 85
2019
Q3
$4.81M Buy
137,587
+14,538
+12% +$559K 0.15% 70
2019
Q2
$5.29M Buy
123,049
+137
+0.1% +$5.68K 0.14% 66
2019
Q1
$5.3M Sell
122,912
-1,362
-1% -$54.8K 0.13% 66
2018
Q4
$4.54M Buy
124,274
+2,402
+2% +$89.2K 0.1% 74
2018
Q3
$4.89M Sell
121,872
-2,290
-2% -$91.5K 0.09% 102
2018
Q2
$4.76M Buy
124,162
+1,187
+1% +$43.7K 0.08% 109
2018
Q1
$4.21M Buy
122,975
+3,617
+3% +$127K 0.07% 120
2017
Q4
$3.92M Buy
+119,358
New +$4.11M 0.06% 130

Other funds holding QGEN

Cambiar Investors's QGEN Position: Q2 2023 in Review

Cambiar Investors sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 11,369 shares — an estimated $554K sold.

Cambiar Investors first reported a position in QGEN in Q4 2017 and held it in 11 quarters. The position peaked at $5.3M in Q1 2019. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

  • Cambiar Investors reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
  • Cambiar Investors sold 11,369 Qiagen shares in Q2 2023, an estimated $554K.
  • Cambiar Investors first reported a position in Qiagen in Q4 2017 and held it in 11 quarters.
  • Cambiar Investors's Qiagen position peaked at $5.3M in Q1 2019.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Cambiar Investors's 13F filing for Q2 2023, filed 31 Jul 2023.